alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 63, Number 77 (Wednesday, April 22, 1998)]
[Notices]
[Pages 19901-19902]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10729]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Oceanic and Atmospheric Administration
[I.D. 032798A]


Marine Mammals

AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and 
Atmospheric Administration (NOAA), Commerce.

ACTION: Issuance of permit amendment.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that Dr. Robin Baird, Marine Mammal 
Research Group, Box 6244, Victoria, B.C., Canada V8P 5L5, has been 
issued an amendment to scientific research Permit No. 926.

ADDRESSES: The amendment and related documents are available for review 
upon written request or by appointment in the following offices:
    Permits Division, Office of Protected Resources, NMFS, 1315 East-
West Highway, Room 13705, Silver Spring, MD 20910 (301/713-2289);
    Regional Administrator, Alaska Region, NMFS, P.O. Box 21668, 
Juneau, AK 99802-1668 (907/586-7221);
    Regional Administrator, Northwest Region, NMFS, 7600 Sand Point 
Way, NE, BIN C15700, Building 1, Seattle, WA 98115-0070 (206/526-6150); 
and
    Regional Administrator, Southwest Region, NMFS, 501 West Ocean 
Boulevard, Suite 4200, Long Beach, CA 90802-4213 (562/980-4001).

SUPPLEMENTARY INFORMATION: On January 30, 1998, notice was published in 
the Federal Register (63 FR 4625) that an amendment of permit No. 926, 
issued June 10, 1994 (59 FR 31217), had been requested by the above-
named individual. The requested amendment

[[Page 19902]]

has been granted under the authority of the Marine Mammal Protection 
Act of 1972, as amended (16 U.S.C. 1361 et seq.), and the provisions of 
Sec. 216.39 of the Regulations Governing the Taking and Importing of 
Marine Mammals (50 CFR part 216).
    Permit No. 926 authorizes: (1) radio tag via suction cup attachment 
up to 25 killer whales (Orcinus orca) and up to 100 Dall's porpoise 
(Phocoenoides dalli) annually in the waters off Washington state over a 
5-year period; and (2) harassment of up to 300 killer whales and 200 
Dall's porpoise annually during the conduct of the tagging activities. 
The purpose of the research is to study the behavior and ecology of 
these species. The Permit has been amended to expand the geographic 
coverage of the research to include the waters of southeast Alaska, 
Oregon, and California and to increase the number of killer whales to 
be tagged, via suction cup, from 25 to 50 to accommodate the expanded 
geographic range of the study.

    Dated: April 16, 1998.
Ann D. Terbush, Chief,
Permits and Documentation Division, Office of Protected Resources, 
National Marine Fisheries Service.
[FR Doc. 98-10729 Filed 4-21-98; 8:45 am]
BILLING CODE 3510-22-F
##### 



Exhibit 31.2
 
  1.
    
    I have reviewed this quarterly report on Form 10-Q of Morton Industrial Group, Inc.;
 2.
    
    Based on my knowledge, this quarterly report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the
period covered by this quarterly report;
 3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this quarterly report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented
in this quarterly report;
 4.
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e))
for the registrant and have:
 a)
    
    designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this quarterly report
is being prepared;b)
    
    evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation;
andc)
    
    disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter that has
materially affected, or is reasonably likely to materially affect, the registrants internal
control over financial reporting; and
 5.
    
    The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors:
 a)
    
    all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information; andb)
    
    any fraud, whether or not material, that involves management or other employees who have
a significant role in the registrants internal control over financial reporting.
# C_2019307EN.01000401.xml

| 11.9.2019 | EN | Official Journal of the European Union | C 307/4 |
| --- | --- | --- | --- |

11.9.2019

EN

Official Journal of the European Union

C 307/4

---

Explanatory Notes to the Combined Nomenclature of the European Union

(2019/C 307/04)

Pursuant to Article 9(1)(a) of Council Regulation (EEC) No 2658/87 (1), the Explanatory Notes to the Combined Nomenclature of the European Union (2) are hereby amended as follows:

On page 211

The following text is inserted:

| 4202 91 80 and 4202 92 19 and 4202 92 98 and 4202 99 00 | Other


  ‘These subheadings include so-called “garment bags” designed for transporting clothes. These bags are made of durable materials and are suitable for prolonged use. They are equipped with carrying handle(s). Generally, in order to make the transport of the bags easier, they can be folded and their halves interconnected by means of buttons, clutches or zippers. Apart from usually having a zip fastener at the front, they are typically equipped with additional closings, compartments, pockets etc.
  However, simple “garment bags” which serve for storing and/or protection and/or short term transport of clothes (for example, after dry cleaning) are excluded (classification according to their constituent material, generally heading 3926 or heading 6307). See also the HS Explanatory note to heading 6307 (6). These bags are generally not equipped with carrying handles and usually contain only a zip fastener at the front for placing the clothes and an opening for inserting a cloth-hanger.’ |
| --- | --- |

4202 91 80 and 4202 92 19 and 4202 92 98 and 4202 99 00

Other

‘These subheadings include so-called “garment bags” designed for transporting clothes. These bags are made of durable materials and are suitable for prolonged use. They are equipped with carrying handle(s). Generally, in order to make the transport of the bags easier, they can be folded and their halves interconnected by means of buttons, clutches or zippers. Apart from usually having a zip fastener at the front, they are typically equipped with additional closings, compartments, pockets etc.

However, simple “garment bags” which serve for storing and/or protection and/or short term transport of clothes (for example, after dry cleaning) are excluded (classification according to their constituent material, generally heading 3926 or heading 6307). See also the HS Explanatory note to heading 6307 (6). These bags are generally not equipped with carrying handles and usually contain only a zip fastener at the front for placing the clothes and an opening for inserting a cloth-hanger.’

---

(1)  Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff (OJ L 256, 7.9.1987, p. 1).

1

(2)  OJ C 119, 29.3.2019, p. 1.

2

---
# C_2019314EN.01000501.xml

| 18.9.2019 | EN | Official Journal of the European Union | C 314/5 |
| --- | --- | --- | --- |

18.9.2019

EN

Official Journal of the European Union

C 314/5

---

Special Report No 14/2019

‘Have your say!’: Commission's public consultations engage citizens, but fall short of outreach activities

(2019/C 314/05)

The European Court of Auditors hereby informs you that Special Report No 14/2019, ‘Have your say!’: Commission's public consultations engage citizens, but fall short of outreach activities has just been published.

The report can be accessed for consultation or downloading on the European Court of Auditors' website: http://eca.europa.eu.

---
Exhibit 99.1   Officer's Certificate regarding Annual Statement of
               Compliance of Washington Mutual Bank

                             WASHINGTON MUTUAL BANK
                              OFFICER'S CERTIFICATE

The  undersigned  officer of  Washington  Mutual  Bank (the  "Servicer")  hereby
certifies  on behalf of the  Servicer  and on his own behalf for purposes of the
WaMu Mortgage Pass-Through Certificates, Series 2005-AR16, as follows:

1. I am the duly appointed and qualified Senior Vice President of the Servicer.

2. Capitalized terms used and not defined herein shall have the meanings
ascribed to such terms in the Pooling and Servicing Agreement related to the
above-referenced series of Certificates.

3. I am duly authorized to execute and deliver this Officer's Certificate on
behalf of the Servicer.

4. A review of the activities of the Servicer during the preceding
calendar year and performance under this Agreement has been made under my
supervision.

5. To the best of my knowledge, based on such review, the Servicer has
fulfilled all its obligations under the Agreement throughout such year.



     IN WITNESS WHEREOF, I have signed my name as of March 1, 2006.





                     WASHINGTON MUTUAL BANK


                     By: /s/ Henry J. Berens
                         -------------------------------------
                         Henry J. Berens
                         Senior Vice President
No. 12-6302.

#### Croft, aka Dark Horse *v.*Henry, Warden, et al.

C. A. 11th Cir. Certiorari denied.
```
[Federal Register Volume 63, Number 80 (Monday, April 27, 1998)]
[Notices]
[Page 20638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-11087]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Gastrointestinal Drugs Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Gastrointestinal Drugs Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on May 28 and 29, 1998, 9 
a.m. to 5 p.m.
    Location: Holiday Inn, Versailles Ballrooms I and II, 8120 
Wisconsin Ave., Bethesda, MD.
    Contact Person: Joan C. Standaert, Center for Drug Evaluation and 
Research (HFD-110), Food and Drug Administration, 5600 Fishers Lane, 
Rockville MD 20857, 419-259-6211, or John B. Schupp (HFD-21), 301-443-
5455, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-
443-0572 in the Washington, DC area), code 12538. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: On May 28, 1998, the committee will discuss biologics 
license application, 98-0012, Centocor, Inc.'s, AvakineTM 
(Infliximab), for treatment of patients with Crohn's disease. An 
indication is sought to: (1) Reduce signs and symptoms in patients with 
moderate to severe disease activity in whom conventional therapies are 
inadequate, and (2) close entercutaneous fistulas. On May 29, 1998, the 
committee will hold a general discussion on guidance for the study of 
drugs to treat Crohn's disease.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by May 21, 1998. 
Oral presentations from the public will be scheduled between 
approximately 9 a.m. and 10 a.m., on May 28, 1998. Time allotted for 
each presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before May 21, 1998, and 
submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: April 17, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 98-11087 Filed 4-24-98; 8:45 am]
BILLING CODE 4160-01-F
```
Exhibit 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Hipso Multimedia, Inc. (the Company), does hereby certify, to such officers knowledge, that the Annual Report on Form 10-K for the fiscal year ended November 30, 2008 of the Registrant fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                            |  |  |  | 
|--------------------------- |  |  |  | 
|March 20, 2009              |  |  |  | 
|/s/ Rene Arbic              |  |  |  | 
|By: Rene Arbic              |  |  |  | 
|Principal Executive Officer |  |  |  |
|                                                                                       
|---------------------------------------------------------------------------------------
|                                                                                       
|View History:  Monthly  Annual Download Data (XLS File)                               
|View History:  Monthly  Annual                                                         
|View History:  Monthly  Annual                                                         
|View History:                                                                          
|                                                                                       
|St. Clair, MI Natural Gas Pipeline Exports to Canada  (Dollars per Thousand Cubic Feet)
|                                                                                       
|                                                                                       
|St. Clair, MI Natural Gas Pipeline Exports to Canada  (Dollars per Thousand Cubic Feet)
|                                                                                       

|Decade                                                                                                                            | Year-0 | Year-1 | Year-2 | Year-3 | Year-4 | Year-5 | Year-6 | Year-7 | Year-8 | Year-9
|--------------------------------------------------------------------------------------------------------------------------------- | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------
|1990's                                                                                                                            |        |        |        |        |        |        | 3.13   | 2.51   | 2.23   | 2.51  
|2000's                                                                                                                            | 3.73   | 3.82   | 3.42   | 6.13   | 6.56   | 7.77   | 7.39   | 7.24   | 8.96   | 4.62  
|2010's                                                                                                                            | 4.86   | 4.45   | 3.11   | 4.07   | 6.39   | 3.20   | 2.64   | 3.15   | 3.40   | 2.70  
|2020's                                                                                                                            | 2.05   | 3.76   | 6.21   | 2.68   |        |        |        |        |        |       
|- = No Data Reported;  -- = Not Applicable;  NA = Not Available;  W = Withheld to avoid disclosure of individual company data.
|                                                                                                                                 
|Release Date: 7/31/2024                                                                                                          
|Next Release Date: 8/30/2024
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Synergy Pharmaceuticals, Inc. (the "Company") on Form 10-K for the
year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Gary S. Jacob, Acting Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



/s/ GARY S. JACOB Gary S. Jacob Chief Executive Officer


March 15,
2010

---



QuickLinks
# C_2019322EN.01000601.xml

| 26.9.2019 | EN | Official Journal of the European Union | C 322/6 |
| --- | --- | --- | --- |

26.9.2019

EN

Official Journal of the European Union

C 322/6

---

Prior notification of a concentration

(Case M.9387 — Allied Irish Banks/First Data Corporation/Semeral)

(Text with EEA relevance)

(2019/C 322/06)

1.

This notification concerns the following undertakings:

| — | Allied Irish Banks (‘AIB’, Ireland), |
| --- | --- |

—

Allied Irish Banks (‘AIB’, Ireland),

| — | First Data Corporation (‘FDC’, USA), and |
| --- | --- |

—

First Data Corporation (‘FDC’, USA), and

| — | Semeral (Ireland). |
| --- | --- |

—

Semeral (Ireland).

AIB and FDC acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of Semeral.

The concentration is accomplished by way of purchase of shares.

2.

| — | AIB is is a financial services group operating predominantly in Ireland, |
| --- | --- |

—

AIB is is a financial services group operating predominantly in Ireland,

| — | FDC provides e-commerce and payment services to businesses worldwide, and |
| --- | --- |

—

FDC provides e-commerce and payment services to businesses worldwide, and

| — | Semeral is the holding company for Payzone Ireland, which operates a multi-channel consumer payments acceptance network in Ireland. |
| --- | --- |

—

Semeral is the holding company for Payzone Ireland, which operates a multi-channel consumer payments acceptance network in Ireland.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9387 — Allied Irish Banks/First Data Corporation/Semeral

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| E-mail: COMP-MERGER-REGISTRY@ec.europa.eu |
| --- |
| Fax: +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

E-mail: COMP-MERGER-REGISTRY@ec.europa.eu

Fax: +32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

---
[Federal Register Volume 63, Number 10 (Thursday, January 15, 1998)]
[Notices]
[Page 2422]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-1055]


=======================================================================
-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Notice of Permits Issued Under the Antarctic Conservation Act of 
1978

AGENCY: National Science Foundation.

ACTION: Notice of permits issued under the Antarctic Conservation Act 
of 1978, Public Law 95-541.

-----------------------------------------------------------------------

SUMMARY: The National Science Foundation (NSF) is required to publish 
notice of permits issued under the Antarctic Conservation Act of 1978. 
This is the required notice.

FOR FURTHER INFORMATION CONTACT:
Nadene G. Kennedy or Joyce Jatko Permit Office, Office of Polar 
Programs, Rm. 755, National Science Foundation, 4201 Wilson Boulevard, 
Arlington, VA 22230.

SUPPLEMENTARY INFORMATION: On November 29, 1997, the National Science 
Foundation published a notice in the Federal Register of a waste 
management permit application received. A permit was issued on December 
24, 1997 to the following applicant: Red Whittaker, Permit #98WM-1.
Nadene G. Kennedy,
Permit Officer.
[FR Doc. 98-1055 Filed 1-14-98; 8:45 am]
BILLING CODE 7555-01-M
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1025 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 1025

To amend title 38, United States Code, to recognize the service in the 
 reserve components of certain persons by honoring them with status as 
                          veterans under law.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 10, 2011

    Mr. Walz of Minnesota (for himself, Mr. Latham, and Mr. Runyan) 
 introduced the following bill; which was referred to the Committee on 
                           Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
To amend title 38, United States Code, to recognize the service in the 
 reserve components of certain persons by honoring them with status as 
                          veterans under law.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PROVISION OF STATUS UNDER LAW BY HONORING CERTAIN MEMBERS OF 
              THE RESERVE COMPONENTS AS VETERANS.

    (a) In General.--Chapter 1 of title 38, United States Code, is 
amended by inserting after section 107 the following new section:
``Sec. 107A. Honoring as veterans certain persons who performed service 
              in the reserve components
    ``Any person who is entitled under chapter 1223 of title 10 to 
retired pay for nonregular service or, but for age, would be entitled 
under such chapter to retired pay for nonregular service shall be 
honored as a veteran but shall not be entitled to any benefit by reason 
of this section.''.
    (b) Clerical Amendment.--The table of sections at the beginning of 
such chapter is amended by inserting after the item relating to section 
107 the following new item:

``107A. Honoring as veterans certain persons who performed service in 
                            the reserve components.''.
                                 <all>
```